Houston, Texas
Stages:
Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
Master of Business Administration (M.B.A.)
(2011 - 2013)
Passed each level on first attempt
(2008 - 2011)
2020
2020
2020
2020
2021
2021
2020
2023
2023
2023
2023
2011
2019
GSTVC is a seed stage venture investment group focusing on B2B SaaS companies that are post revenue and post product but still early in the revenue cycle.
2011
GST provides software development services to software businesses and entrepreneurs with great ideas. We are an innovation engine designed to power your business with flexible development teams to meet any budget or time frame. At GSV, Dougal: • Led a software development services company, growing the team from two developers to more than fifty in eighteen months. • Ran business development for the software development services company. • Created several Chinese corporation subsidiaries to handle custody of IP and provide tighter security structures.
2013
2013
GSV invests in software and software assisted service businesses. Along with sourcing capital, GSV can add value on strategic growth and tech strategy. At GSV, Dougal has: • Participated in the buyout of Prognosis Innovation Healthcare: raising funding, structuring the deal, and supplying development talent through the software development services company. • Lead the restructure and turnaround of Prognosis culminating in the sale of the business to Azalea Health Innovations, a Kayne Anderson portfolio company.
2017 - 2018
2017 - 2018
2017 - 2017
Dougal served as an advisor to the executive team at Azalea Health following the acquisition of Prognosis to assist in the transition and ensure a smooth continuity of operations, expectations, and results.
2014 - 2017
2014 - 2017
Dougal stepped into Prognosis as the CEO in September 2015. In this role, he reorganized the company by flattening the organization, installing systems and higher levels of authority with front-line staff, and redesigned the delivery of service. These efforts and a stellar team gave rise to a period of growth for Prognosis that resulted in a 40% annual revenue growth rate. After a year of performance, Dougal led efforts around a growth capital campaign that resulted in the successful merger of Prognosis with Azalea Health Innovations, Inc.